Andriole Michael T.
PRESIDENT AND CEO at CHIMERIX INC; Chief Financial Officer at ENDOCYTE INC
- Sold, on record
- $325k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 13, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CHIMERIX INCPRESIDENT AND CEO
- ENDOCYTE INCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ENDOCYTE INC17,918 shares
- CHIMERIX INC12,749 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ENDOCYTE INCPlan not statedOct 9 2018
Sold 17,918 shares at $15.56 ($279k)
Andriole Michael T., Chief Financial Officer
Sold 11.9% of holdings ($2.3M position)132,082 shares leftFirst sale on recordFiling
- 2 Form 144 notice CHIMERIX INCNoticeFeb 14 +1954 days
Filed to sell 2,000 shares ($2k)
Andriole Michael T., Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale CHIMERIX INCNo planFeb 14 same day
Sold 1,744 shares at $1.04 ($2k)
Andriole Michael T., PRESIDENT AND CEO
No 10b5-1 planSold 0.4% of holdings ($467k position)447,021 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale CHIMERIX INCNo planAug 8 +176 days
Sold 1,285 shares at $0.83 ($1k)
Andriole Michael T., PRESIDENT AND CEO
No 10b5-1 planSold 0.3% of holdings ($385k position)462,453 shares leftFiling
- 5 Form 4 sale CHIMERIX INCNo planJan 30 +175 days
Sold 2,350 shares at $4.10 ($10k)
Andriole Michael T., PRESIDENT AND CEO
No 10b5-1 planSold 0.4% of holdings ($2.5M position)616,973 shares leftFiling
- 6 Form 4 sale CHIMERIX INCUnusualFeb 13 +14 days
Sold 7,370 shares at $4.52 ($33k)
Andriole Michael T., PRESIDENT AND CEO
No 10b5-1 planSold 1.2% of holdings ($2.8M position)609,603 shares left4.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | CHIMERIX INC | PRESIDENT AND CEO | Form 4 sale | 7,370 | $33k | 1.2% | Unusual | SEC |
| Jan 30, 2025 | CHIMERIX INC | PRESIDENT AND CEO | Form 4 sale | 2,350 | $10k | 0.4% | No plan | SEC |
| Aug 8, 2024 | CHIMERIX INC | PRESIDENT AND CEO | Form 4 sale | 1,285 | $1k | 0.3% | No plan | SEC |
| Feb 14, 2024 | CHIMERIX INC | PRESIDENT AND CEO | Form 4 sale | 1,744 | $2k | 0.4% | No plan | SEC |
| Feb 14, 2024 | CHIMERIX INC | Officer | Form 144 notice | 2,000 | $2k | Notice | SEC | |
| Oct 9, 2018 | ENDOCYTE INC | Chief Financial Officer | Form 4 sale | 17,918 | $279k | 11.9% | Plan not stated | SEC |